JP2015523346A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015523346A5 JP2015523346A5 JP2015516261A JP2015516261A JP2015523346A5 JP 2015523346 A5 JP2015523346 A5 JP 2015523346A5 JP 2015516261 A JP2015516261 A JP 2015516261A JP 2015516261 A JP2015516261 A JP 2015516261A JP 2015523346 A5 JP2015523346 A5 JP 2015523346A5
- Authority
- JP
- Japan
- Prior art keywords
- day
- neutropenia
- retinoid agonist
- pharmaceutical composition
- administration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261656815P | 2012-06-07 | 2012-06-07 | |
| US61/656,815 | 2012-06-07 | ||
| PCT/US2013/044828 WO2013185105A1 (en) | 2012-06-07 | 2013-06-07 | Methods for treating neutropenia using retinoid agonists |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015523346A JP2015523346A (ja) | 2015-08-13 |
| JP2015523346A5 true JP2015523346A5 (https=) | 2016-06-16 |
| JP6295249B2 JP6295249B2 (ja) | 2018-03-14 |
Family
ID=49712715
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015516261A Expired - Fee Related JP6295249B2 (ja) | 2012-06-07 | 2013-06-07 | レチノイドアゴニストを用いた好中球減少症の治療方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US11116738B2 (https=) |
| EP (1) | EP2858636B1 (https=) |
| JP (1) | JP6295249B2 (https=) |
| KR (1) | KR102083046B1 (https=) |
| CN (1) | CN104519879B (https=) |
| AU (1) | AU2013270674B2 (https=) |
| BR (1) | BR112014030279A2 (https=) |
| CA (1) | CA2874850A1 (https=) |
| ES (1) | ES2691493T3 (https=) |
| MX (1) | MX365321B (https=) |
| NZ (1) | NZ702415A (https=) |
| RU (1) | RU2650962C2 (https=) |
| WO (1) | WO2013185105A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ702415A (en) | 2012-06-07 | 2016-04-29 | Children’S Hospital Los Angeles | Methods for treating neutropenia using retinoid agonists |
| WO2014145295A1 (en) | 2013-03-15 | 2014-09-18 | Avisenna Cosmetics, Llc | Topical compositions for reducing aging effects |
| KR20160113302A (ko) * | 2014-02-18 | 2016-09-28 | 칠드런＇스 하스피틀 로스 앤젤레스 | 호중구감소증을 치료하기 위한 조성물 및 방법 |
| MX391949B (es) | 2015-03-31 | 2025-03-21 | Syros Pharmaceuticals Inc | Metodos para estratificacion de pacientes para tratamiento con agonistas del receptor alfa de acido retinoico. |
| US9868994B2 (en) | 2016-04-08 | 2018-01-16 | Syros Pharmaceuticals, Inc. | Methods of stratifying patients for treatment with retinoic acid receptor-α agonists |
| TW201823471A (zh) * | 2016-10-06 | 2018-07-01 | 美商錫羅斯製藥公司 | 以視黃酸受體-α促效劑及抗CD38抗體治療病患之方法 |
| WO2019147187A1 (en) * | 2018-01-26 | 2019-08-01 | Agency For Science, Technology And Research | Neutrophil subtypes |
| CN113969261B (zh) * | 2020-07-06 | 2024-04-09 | 苏州市立医院(北区) | 三步法快速测定中性粒细胞趋化的方法 |
| US20220378727A1 (en) * | 2021-05-14 | 2022-12-01 | The University Of Hong Kong | Dry powder formulations of tamibarotene for pulmonary and intranasal delivery |
| FI131561B1 (en) * | 2023-12-28 | 2025-06-30 | Faron Pharmaceuticals Oy | CLEVER-1 INHIBITOR TO PROMOTE HEMATOLOGICAL RECOVERY WHEN USING CHEMOTHERAPY |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5691196A (en) | 1992-12-31 | 1997-11-25 | American Cyanamid Company | Recombinant nucleic acid containing a response element |
| US5965606A (en) | 1995-12-29 | 1999-10-12 | Allergan Sales, Inc. | Methods of treatment with compounds having RAR.sub.α receptor specific or selective activity |
| CA2273288A1 (en) * | 1996-12-19 | 1998-06-25 | James Joseph Gibbons | Method of treating or inhibiting neutropenia |
| JP4799803B2 (ja) | 2000-09-08 | 2011-10-26 | マサチューセッツ インスティテュート オブ テクノロジー | Ｇ−ｃｓｆアナログ組成物および方法 |
| US7119061B2 (en) | 2002-11-18 | 2006-10-10 | Vicuron Pharmaceuticals, Inc. | Dalbavancin compositions for treatment of bacterial infections |
| EP1632241A4 (en) | 2003-05-16 | 2009-07-22 | Kyowa Hakko Kirin Co Ltd | MEANS FOR THE PREVENTION AND / OR HEALING OF DISEASES IN CONNECTION WITH TISSUE DISORDER |
| EP1621191A1 (en) * | 2004-07-29 | 2006-02-01 | Werner Bollag | Treatment of inflammatory diseases by RXR Antagonists |
| JP2008509928A (ja) | 2004-08-13 | 2008-04-03 | アノーメド インコーポレイテッド | 前駆／幹細胞を動員するためのケモカインの組み合わせ |
| PT1841432E (pt) | 2004-12-02 | 2010-10-25 | Venus Remedies Ltd | Composições para combater a resistência aos antibióticos mediada pela beta-lactamase usando inibidores da betalactamase úteis para injecção |
| WO2006071451A2 (en) | 2004-12-03 | 2006-07-06 | The Regents Of The University Of California | Compounds that prevent macrophage apoptosis and uses thereof |
| DK2026778T3 (en) * | 2006-05-16 | 2019-01-07 | Io Therapeutics Llc | RAR ANTAGONIST OR INVERSE AGONIST FOR USE IN THE TREATMENT OF CHEMOTHERAPY AND / OR RADIATION THERAPY SIDE EFFECTS |
| WO2008120711A1 (ja) | 2007-03-30 | 2008-10-09 | Tmrc Co., Ltd. | タミバロテンカプセル剤 |
| US20110052574A1 (en) * | 2007-12-06 | 2011-03-03 | Csl Limited | Method of inhibition of leukemic stem cells |
| WO2010028388A1 (en) | 2008-09-05 | 2010-03-11 | Solulink Biosciences, Inc. | Methods and compositions for direct detection of dna damage |
| AU2010309388B2 (en) | 2009-10-19 | 2016-03-10 | Laila Nutraceuticals | Extracts, fractions and compositions comprising acetogenins and their applications |
| RU2446173C1 (ru) | 2010-08-13 | 2012-03-27 | Зао "Биокад" | Новый функционально активный, высокоочищенный стабильный конъюгат гранулоцитарного колониестимулирующего фактора (г-ксф) с полиэтиленгликолем с пролонгированным биологическим действием, пригодный для медицинского применения, и иммунобиологическое средство на его основе |
| CN102380090A (zh) | 2010-08-31 | 2012-03-21 | 健能隆医药技术（上海）有限公司 | G-csf二聚体在治疗嗜中性粒细胞减少症中的应用 |
| WO2012109208A2 (en) | 2011-02-08 | 2012-08-16 | Cellular Dynamics International, Inc. | Hematopoietic precursor cell production by programming |
| JP6242868B2 (ja) | 2012-05-08 | 2017-12-06 | リセラ・コーポレイションＬｙｃｅｒａ Ｃｏｒｐｏｒａｔｉｏｎ | ＲＯＲγのアゴニストとしての使用のためおよび疾患の処置のためのテトラヒドロ［１，８］ナフチリジンスルホンアミドおよび関連化合物 |
| NZ702415A (en) | 2012-06-07 | 2016-04-29 | Children’S Hospital Los Angeles | Methods for treating neutropenia using retinoid agonists |
| DE102012011766B3 (de) | 2012-06-15 | 2013-12-19 | Voith Patent Gmbh | Getriebeeinheit |
| CN104758922A (zh) | 2014-01-03 | 2015-07-08 | 上海泽生科技开发有限公司 | 纽兰格林制剂的配方 |
| KR20160113302A (ko) | 2014-02-18 | 2016-09-28 | 칠드런＇스 하스피틀 로스 앤젤레스 | 호중구감소증을 치료하기 위한 조성물 및 방법 |
-
2013
- 2013-06-07 NZ NZ702415A patent/NZ702415A/en not_active IP Right Cessation
- 2013-06-07 EP EP13800873.5A patent/EP2858636B1/en not_active Not-in-force
- 2013-06-07 ES ES13800873.5T patent/ES2691493T3/es active Active
- 2013-06-07 WO PCT/US2013/044828 patent/WO2013185105A1/en not_active Ceased
- 2013-06-07 US US14/405,141 patent/US11116738B2/en active Active
- 2013-06-07 MX MX2014014930A patent/MX365321B/es active IP Right Grant
- 2013-06-07 BR BR112014030279A patent/BR112014030279A2/pt not_active Application Discontinuation
- 2013-06-07 JP JP2015516261A patent/JP6295249B2/ja not_active Expired - Fee Related
- 2013-06-07 CN CN201380041537.6A patent/CN104519879B/zh not_active Expired - Fee Related
- 2013-06-07 AU AU2013270674A patent/AU2013270674B2/en not_active Ceased
- 2013-06-07 KR KR1020157000014A patent/KR102083046B1/ko not_active Expired - Fee Related
- 2013-06-07 RU RU2014153988A patent/RU2650962C2/ru not_active IP Right Cessation
- 2013-06-07 CA CA2874850A patent/CA2874850A1/en not_active Abandoned